Delivering drugs to gut tumors can be tricky. Researchers at Washington University in St. Louis have engineered an oral ...

New insights into the impact of checkpoint inhibitors on the immune system may enhance cancer treatment strategies. A ...

The European Commission’s decision is based on two Phase III trials where Tevimbra plus chemotherapy improved overall ...

A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation for why some cancer patients receiving a type of immunotherapy called checkpoint ...

Findings indicate a serine/glycine-free diet can reduce colorectal cancer growth and enhance immune response, offering ...

Studying patients with PD-1 or PD-L1 deficiency may help inform new approaches to fine-tuning immunotherapies to maximise ...

PD-L1 expression was found to predict better outcomes with Opdivo and Yervoy in patients with ccRCC, while high KIM-1 levels ...

A cancer treatment from Roche failed to improve survival in a major lung cancer study, a result that will stoke doubts about ...

A review discussing the therapeutic potentials of NK cell biology has been published in the journal Frontiers of Medicine.

boulardii is a yeast strain that has been designed for a new purpose: treating colorectal cancer. Dantas’ team inserted ...

Tiragolumab is a novel immune checkpoint inhibitor that binds to TIGIT, a protein receptor on immune cells, which suppresses ...

Discover which therapies are expected to grab the PD/L-1 Market Share @ PD/L-1 Treatment Market Size ...